½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1499330

¼¼°èÀÇ ÇÇÆêÆà ·Îº¿ ½ÃÀå : Àü¸Á ¹× ¿¹Ãø(2024-2029³â)

Pipetting Robots Market - Global Outlook & Forecast 2024-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Arizton Advisory & Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 297 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÇÇÆêÆà ·Îº¿ ½ÃÀå ±Ô¸ð´Â 2023³âºÎÅÍ 2029³â¿¡ °ÉÃÄ CAGR 7.48%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ

ÇÇÆêÆà ·Îº¿ ÅëÇÕ°ú »õ·Î¿î ¼Ö·ç¼Ç °³¹ß Áõ°¡

ÇÇÆêÆà ·Îº¿ ½ÃÀåÀº Áö³­ ¸î ³âµ¿¾È Å©°Ô ¹ßÀüÇß½À´Ï´Ù. ÀϺΠ±â¾÷Àº ½ÅÁ¦Ç°À» °³¹ßÇÏ°í Ä«¸Þ¶ó, UV ¶óÀÌÆ®, ¿¬°á ÀåÄ¡, ¼ÒÇÁÆ®¿þ¾î, °í±Þ ºÐÁÖ Çìµå µî ÇÇÆêÆà ·Îº¿¿¡ ÅëÇÕÇϱâ À§ÇÑ »õ·Î¿î ±â¼ú°ú µµ±¸¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¿¹¸¦ µé¾î, Festo´Â °í¼Ó ·Îº¿ ºÐ¹è¿ë DHOP Æó¼â ·çÇÁ ÇÇÆê Çìµå¸¦ ¹ßÇ¥Çß½À´Ï´Ù.

ÃÖ±Ù M&A

ÇÇÆêÆà ·Îº¿Àº ±Þ¼ºÀåÇÏ´Â »ê¾÷ÀÌ¸ç ½ÃÀå °æÀïµµ °ÝÈ­ÇÏ°í ÀÖ½À´Ï´Ù. °ø±Þ¾÷ü °£ °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÇÇÆêÆà ·Îº¿À» Æ÷ÇÔÇÑ ÀÚµ¿ ¸®Äûµå Çڵ鸵 ¼Ö·ç¼ÇÀÇ °­È­¸¦ À§ÇØ M&A, Çùµ¿, Á¦ÈÞ µî Àü·«ÀûÀÎ ºñÁî´Ï½º ¸ðµ¨·ÎÀÇ ÀüȯÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 1¿ù Waters´Â Andrew Alliance¸¦ ÀμöÇß½À´Ï´Ù. Andrew Alliance´Â ½ÇÇè½Ç ÀÚµ¿È­ ±â¼ú, ·Îº¿ °øÇÐ ¹× ¼ÒÇÁÆ®¿þ¾î¸¦ Àü¹®À¸·Î ÇÕ´Ï´Ù. ÀÌ Àμö¸¦ ÅëÇØ Hamilton's´Â ÀÚµ¿ ¸®Äûµå Çڵ鸵 ¹× ±âŸ ½ÇÇè½Ç µµ±¸¿ë °í±Þ ·Îº¿ ¹× ¼ÒÇÁÆ®¿þ¾î¸¦ Æ÷ÇÔÇÑ ±â¼ú Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù.

¿©·¯ »ê¾÷¿¡ °ÉÄ£ ½ÇÇè½Ç ÀÚµ¿È­ Áõ°¡

½ÇÇè½Ç ÀÚµ¿È­´Â ¼Óµµ°¡ ºü¸¥ °úÇÐ ¹× ¿¬±¸ ÇöÀå¿¡¼­ÀÇ ¿¬±¸ ÀýÂ÷¸¦ °­È­ÇÕ´Ï´Ù. °£¼ÒÈ­µÈ ¿öÅ©Ç÷οì¿Í ¹Ýº¹ ÀÛ¾÷À» ÀÚµ¿È­ÇÔÀ¸·Î½á ½ÇÇè½ÇÀº ÀϹÝÀûÀ¸·Î ¾÷¹«¿¡¼­ ´õ ³ôÀº Á¤È®¼º°ú È¿À²¼ºÀ» ´Þ¼ºÇÕ´Ï´Ù. ÃÖ±Ù, ½ÇÇè½Ç °úÇÐÀº ÀÚµ¿È­¿Í ÇÔ²² ²÷ÀÓ¾øÀÌ ÁøÈ­ÇÏ°í ÀÖÀ¸¸ç, ±â¼ú ¹ßÀüÀº °úÇÐÀû ½Ãµµ¸¦ °­È­ÇÒ »õ·Î¿î °¡´É¼ºÀ» ¿­°í ÀÖ½À´Ï´Ù.

»ý¸í °úÇÐ ºÐ¾ß¿¡¼­ R&D¿Í ½ÇÇè½Ç ¼ö Áõ°¡

»ý¸í°úÇÐ »ê¾÷Àº R&D È°µ¿¿¡ ´ëÇÑ ÅõÀÚ¸¦ Áö¼ÓÀûÀ¸·Î ´Ã¸®°í ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ¾÷°è¿¡¼­´Â ½ÇÇè½Ç ·Îº¿, ÀΰøÁö´É, ÀÎÁö ¿ÀÅä¸ÞÀ̼Ç, ½ÇÁ¦ ¼¼°è Áõ°Å ¹× ±âŸ ¿©·¯ ÀÚµ¿È­ ¼Ö·ç¼Ç°ú °°Àº ÷´Ü ±â¼ú°ú Çõ½ÅÀÌ ÇÇÆêÆà ·Îº¿ÀÇ µµÀÔÀ» °¡¼ÓÈ­ÇÏ°í ÀÖ½À´Ï´Ù. ÀÓ»ó ¿¬±¸, ÀǾàÇ° ¹× Á¦Á¶¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖÀ¸¸ç, ±× °á°ú ½ÇÇè½Ç¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÏ°í ÇÇÆêÆà ·Îº¿¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. »ý¸í°úÇбâ¾÷Àº R&D ºÎ¼­¿¡ Á¡Á¡ ´õ ÈûÀ» ½ñ°í ÀÖÀ¸¸ç, ȯÀÚ¿Í °Ç°­À» °³¼±ÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ »õ·Î¿î Ä¡·á¹ýÀ» ½ÃÀå¿¡ ÅõÀÔÇÏ°í ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ¾÷°è´Â °æÀï·ÂÀ» À¯ÁöÇÏ°í ¼¼°èÀÇ ¿ä±¸ º¯È­¿¡ ´ëÀÀÇϱâ À§Çؼ­´Â R&D¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ°¡ ÇʼöÀûÀ̶ó´Â °ÍÀ» ÀνÄÇÏ°í ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç, »ý¸í°øÇÐȸ»ç, ÀÇ·á±â±âȸ»ç µî »ý¸í°úÇÐ ºÐ¾ßÀÇ °³¹ßÀÌ ÁøÇàµÊ¿¡ µû¶ó ÷´Ü R&D Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÇÇÆêÆà ·Îº¿ ½ÃÀåÀÇ ¼ºÀåÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

Á¦Ç°º° ÅëÂû·Â

¿ÏÀü ÀÚµ¿ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ¿ÏÀü ÀÚµ¿ ÇÇÆêÆà ·Îº¿Àº È¿À²¼º°ú Á¤È®¼ºÀ¸·Î ½ÇÇè½Ç ÀÛ¾÷ ºÎ´ãÀ» Å©°Ô ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ°ÍÀº ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¿ëµµº° ÅëÂû·Â

â¾à °³¹ß ºÎ¹®ÀÌ 2023³â ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß ½ÃÀåÀ» ¼±µµÇÒ Àü¸ÁÀÔ´Ï´Ù. â¾à ¹× °³¹ß ºÎ¹®¿¡¼­ ÇÇÆêÆà ·Îº¿Àº Á¦¾à ¹× »ý¸í °øÇРȸ»ç ÀüüÀÇ ÀÓ»ó½ÃÇè È°µ¿, ƯÈ÷ ¼ö¹é¸¸ÀÇ °Ë»ç ¹× È­ÇÕ¹° ºÐ¼® ½ºÅ©¸®´×¿¡¼­ ¼öµ¿ ½Ç¼ö °¡´É¼ºÀ» ÁÙÀÌ°í ºñ¿ëÀ» Àý°¨ÇÕ´Ï´Ù. °¡Àå Áß¿äÇÑ ÀÚµ¿ ½ÇÇè½Ç Àåºñ·Î °£Áֵ˴ϴÙ.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ÇÇÆêÆà ·Îº¿ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå Á¤ÀÇ¿Í °³¿ä, ÁÖ¿ä µ¿Ç⡤½ÃÀå ±âȸ, ½ÃÀå ¿µÇâ¿äÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹üÀ§¡¤´ë»ó ¹üÀ§

Á¦2Àå Áß¿ä ÀλçÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¼Ò°³

  • °³¿ä
    • ½ÇÇè½Ç ÀÚµ¿È­
    • ½ÇÇè½Ç ÀÚµ¿È­ÀÇ Áøº¸: Á¤¹Ðµµ¿Í È¿À²¼º
    • COVID-19°¡ ÇÇÆêÆà ·Îº¿ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ½ÃÀå ±âȸ¿Í µ¿Çâ

  • ÇÇÆêÆà ·Îº¿ÀÇ ±â¼úÀû Áøº¸
  • ÇÇÆêÆà ·Îº¿ÀÇ »õ·Î¿î ¼Ö·ç¼Ç ÅëÇÕ ¹× °³¹ß °­È­
  • ÃÖ±Ù »ê¾÷ M&A

Á¦6Àå ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

  • ¿©·¯ ¾÷°è¿¡¼­ ½ÇÇè½Ç ÀÚµ¿È­ Áõ°¡
  • »ý¸í°úÇÐ ºÐ¾ß¿¡¼­ R&D¿Í ½ÇÇè½Ç È®Àå Áõ°¡
  • ½ÇÇè½ÇÀÇ ºÎºÐ ÀÚµ¿È­ ¸ðµ¨¿¡¼­ ¿ÏÀü ÀÚµ¿È­ ¸ðµ¨·ÎÀÇ Àüȯ

Á¦7Àå ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

  • ÇÇÆêÆà ·Îº¿º¸´Ù ¼öµ¿ ÇÇÆê°ú ÀüÀÚ ÇÇÆêÀÇ ÀαⰡ °è¼Ó
  • ÇÇÆêÆà ·Îº¿ÀÇ ÀÎü °øÇÐ
  • ÇÇÆêÆà ·Îº¿°ú °ü·ÃµÈ ºñ¿ë ºÎ´ã

Á¦8Àå ½ÃÀå »óȲ

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • Porter's Five Forces ºÐ¼®

Á¦9Àå Á¦Ç°

  • ½ÃÀå ÇöȲ°ú ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå °³¿ä
  • ¿ÏÀü ÀÚµ¿
  • ¹ÝÀÚµ¿
    • ½ÃÀå °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • Áö¿ªº° ½ÃÀå

Á¦10Àå ¿ëµµ

  • ½ÃÀå ÇöȲ°ú ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå °³¿ä
  • â¾à alc °³¹ß
  • ÀÓ»ó Áø´Ü
  • ±âŸ
    • ½ÃÀå °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • Áö¿ªº° ½ÃÀå

Á¦11Àå ÃÖÁ¾ »ç¿ëÀÚ

  • ½ÃÀå ÇöȲ°ú ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå °³¿ä
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú¿¬±¸¼¾ÅÍ
  • ÀÓ»ó Áø´Ü ½ÇÇè½Ç
  • ±âŸ
    • ½ÃÀå °³¿ä
    • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • Áö¿ªº° ½ÃÀå

Á¦12Àå Áö¿ª

  • ½ÃÀå ÇöȲ°ú ¼ºÀå ÃËÁø¿äÀÎ
  • Áö¸®Àû °³¿ä

Á¦13Àå ºÏ¹Ì

Á¦14Àå À¯·´

Á¦15Àå ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦16Àå ¶óƾ¾Æ¸Þ¸®Ä«

Á¦17Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦18Àå °æÀï ±¸µµ

  • °æÀï °³¿ä
  • ½ÃÀå Á¡À¯À² ºÐ¼®

Á¦19Àå ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • AGILENT TECHNOLOGIES
  • BECKMAN COULTER
  • BRAND GMBH CO KG
  • EPPENDORF
  • HAMILTON COMPANY
  • TECAN TRADING AG
  • WATERS

Á¦20Àå ±âŸ ÁÖ¿ä º¥´õ

  • ANALYTIK JENA GMBH CO. KG
  • CYBERTRON
  • CORNING INCORPORATED
  • ESSERT GMBH
  • FLOW ROBOTICS
  • FORMULATRIX
  • GILSON INCORPORATED
  • HUDSON ROBOTICS
  • HIGHRES BIOSOLUTIONS
  • INTEGRA BIOSCIENCES
  • METTLER TOLEDO
  • M2-AUTOMATION GMBH
  • MGI TECH CO., LTD
  • OPENTRONS
  • REVVITTY(PERKINELMER INC.)
  • SPT LABTECH
  • SYNCHRON

Á¦21Àå º¸°í¼­ ¿ä¾à

  • Áß¿ä Æ÷ÀÎÆ®
  • Àü·«Àû Á¦¾È

Á¦22Àå Á¤·®Àû ¿ä¾à

  • Áö¿ªº° ½ÃÀå
  • Á¦Ç°º° ½ÃÀå
  • ¿ëµµº° ½ÃÀå
  • ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀå
  • Á¦Ç°:Áö¿ªº° ½ÃÀå
  • ¿ëµµ:Áö¿ª ½ÃÀå
  • ÃÖÁ¾ »ç¿ëÀÚ : Áö¿ªº° ½ÃÀå

Á¦23Àå ºÎ·Ï

JHS 24.06.28

The global pipetting robots market is expected to grow at a CAGR of 7.48% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Increasing Integration & Development of New Solutions for Pipetting Robots

The pipetting robot market has significantly developed in the past couple of years. Some companies have developed new products and launched new technologies and tools to integrate them into pipetting robots, such as cameras, UV light, connected devices, software, advanced pipetting heads, and others. For instance, Festo introduced the DHOP Closed-loop pipette head for high-speed robotic pipetting.

Recent Industrial Merger & Acquisitions

Pipetting robots is a rapidly growing industry with increasing competition among market players. With the rising competition among vendors, they are turning towards strategic business models, including mergers and acquisitions (M&A), collaboration, and partnerships to enhance automated liquid handling solutions, including pipetting robots. For instance, in January 2020, Waters acquired Andrew Alliance. Andrew Alliance specializes in laboratory automation technology, robotics, and software. This acquisition helped Hamilton's company expand its technology portfolio to include advanced robotics and software for automated liquid handling and other lab tools.

Increasing Lab Automation Across Several Industries

Lab automation enhances R&D procedures in the fast-paced scientific and research landscape. By automating streamlined workflows and repetitive tasks, laboratories achieve higher accuracy and efficiency in regular operations. In recent years, laboratory science has constantly evolved with automation, with technological advancements opening up new possibilities to enhance scientific attempts.

Increasing R&D & Number of Laboratories in the Life Sciences Sector

The life sciences sector continuously increases its investment in research and development activities. In life sciences industries, advanced technologies and innovations such as laboratory robotics, AI, cognitive automation, real-world evidence, and several other automation solutions are accelerating the adoption of pipetting robots. The demand for clinical research, drug discovery, and manufacturing is rising, resulting in increased investment in laboratories and demand for pipetting robots. Life sciences companies are increasingly focusing on their R&D departments to bring new, innovative treatments to market to drive better patients and health outcomes. Life sciences industries realize that investing heavily in R&D is essential to stay competitive and meet the world's changing needs. Increasing development in the life sciences sector, such as pharmaceutical, biotech, and medical devices companies, led to increased demand for advanced lab and research tools, accelerating the growth of the pipetting robots market.

A Shift from Partial to Fully Automated Models in Laboratories

In the past ten years (2013 to 2023), the demand for lab automation increased compared to previous times as the development in the clinical industry has increased since 2011. Laboratory automation is one of the significant evolutions in life sciences companies and medical industries. In 2000, only around 2,000 to 2,500 clinical laboratories implemented some proportion of laboratory automation worldwide; however, in recent years, almost every clinical lab is aware of lab automation and uses lab automation tools in daily activities.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT

The fully automated product segment holds the most significant share of the global pipetting robots market 2023. Fully automated pipetting robots reduce significant lab work burden with efficacy and accuracy. This is the major factor accelerating segmental growth. Fully automated pipetting robots are highly versatile, enable high-speed sample processing, and are vital during large liquid sample handling. As the burden of sample processing increases, more laboratories are turning towards automation and installing fully automated pipetting robots. Fully automated pipetting systems help to reduce labor requirements and save significant time in lab operations. Management is an evident advantage of automated sample processing systems like pipetting robots. Fully automated pipetting robot systems are compatible with multichannel pipetting systems, eliminating the repetitive task of routine pipetting. Also, these systems offer total automation, increasing time for other lab activities and saving the maximum labor cost. Labor shortages in laboratories are a major concern across several geographies where robotic pipetting systems are in high demand.

Segmentation by Product

  • Fully Automated
  • Semi-Automated

INSIGHTS BY APPLICATION

The global pipetting robots market by application is segmented into drug discovery & development, clinical diagnostics, and other applications. In 2023, the drug discovery and development segment accounted for the highest market share and will dominate the market during the forecast period. In drug discovery and development, pipetting robots are considered the most important automated lab equipment to reduce manual error chances and the costs of clinical trial activities across pharma & biotech companies, specifically in screening millions of tests and compound analyses. Pharma and biotech companies invest billions of dollars in clinical studies where human or lab equipment errors can lead to significant cost burdens and failure of new drugs. It fuels the demand for pipetting robots in drug discovery and development procedures.

Segmentation by Application

  • Drug Discovery & Development
  • Clinical Diagnostics
  • Other Applications

INSIGHTS BY END-USER

The global pipetting robots market by end-user is segmented into pharma & biotech companies, academic research centers, clinical diagnostic laboratories, and other end-users. The demand for pipetting robots is high in pharma and biotech companies due to continued engagement in clinical studies and R&D activities where pipetting robots have proven effective. In 2023, the pharmaceutical and biotech companies segment accounted for the highest market share in the global pipetting robots market. Pharmaceutical and biotechnology are leading sectors across the life sciences industries with huge potential to accelerate the demand for the market. Pharmaceutical companies' laboratories are constantly engaged in R&D and drug discovery. Thousands of laboratory operations are regularly done across pharmaceutical company labs where the burden of lab activities and demand for lab automation solutions is constantly increasing. On the other hand, academic research institutes and research centers that run publicly or privately demand robotic pipetting systems for research and academic purposes and contribute to market growth.

Segmentation by End-user

  • Pharma & Biotech Companies
  • Academic Research Centers
  • Clinical Diagnostic Laboratories
  • Other End-users

GEOGRAPHICAL ANALYSIS

North America dominated the global pipetting robots market and accounted for more than 37% of the global market share in 2023. In North America, the demand for pipetting robots is significantly high due to the increasing preferences for lab automation tools, high-tech infrastructure of laboratories, increasing investment in laboratories, presence of pharma & biotech companies, and high expenditure on diagnosis. These factors accelerate the market growth in North America. Furthermore, in North America, the U.S. held a significant market share 2023 across the region and showed dominance over all the global countries. In the U.S., around 75% of clinical decisions depend on laboratory testing. This factor drives significant demand for automation in clinical labs and accelerates the adoption rate of pipetting robots in clinical laboratory settings.

Europe holds a significant position in the global pipetting robots market. Also, it is a well-developed market for scientific research and development activities. These factors increased automation in life sciences, healthcare, and other industrial labs and drove high demand for automated lab tools, including pipetting robots. The pharmaceutical and biotech companies and their long history of research and development in the life sciences and healthcare sector deliver the demand for automated lab systems in various laboratories. Furthermore, APAC has a rapidly growing pipetting robots market that is projected to witness the fastest growth rate in the global market during the forecast period. In APAC, China and Japan drive the huge demand for automated laboratory systems in the pharma-biotech and healthcare industry.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Poland
  • APAC
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE

VENDOR LANDSCAPE

The global pipetting robots market has witnessed highly competitive rivalry among market players. Globally, the presence of leading, rapidly growing, and emerging players impacts the industry landscape. Several players showed continuous dominance, and some companies tried to achieve more market penetration and share. Based on the huge competitive landscape, leading companies accepted and implemented several business strategies focusing on expanding industry share and presence. Pipetting robots are advanced tools continuously evolving with development and innovations, leading to increased competitive rivalry among vendors. It results in companies focusing on new product development, product portfolio expansion, merger and acquisition, collaborations, and partnerships. Furthermore, Agilent Technologies, Beckman Colter, Eppendorf, and Hamilton Company are leading companies with significant global pipetting robots market share, market penetration, and geographical presence. Besides these vendors, BRAND GMBH + CO KG, Gilson, Waters, and INTEGRA Biosciences are other prominent vendors who are highly active in the pipetting robots market.

Key Company Profiles

  • Agilent Technologies
  • Business Overview
  • Product Offerings
  • Key Strategies
  • Key Strengths
  • Key Opportunities
  • Beckman Coulter
  • BRAND GMBH CO + KG
  • Eppendorf
  • Hamilton Company
  • Tecan Trading Ag
  • Waters

Other Prominent Vendors

  • Analytik Jena GmbH+Co. KG
  • Business Overview
  • Product Offerings
  • CYBERTRON GmbH
  • Corning Incorporated
  • ESSERT GMBH
  • Flow Robotics
  • FORMULATRIX
  • Gilson Incorporated
  • Hudson Robotics
  • HighRes Biosolutions
  • INTEGRA Biosciences
  • METTLER TOLEDO
  • M2-Automation GmbH
  • MGI Tech Co., Ltd
  • Opentrons
  • Revvity (PerkinElmer Inc)
  • SPT Labtech
  • SYNCHRON

KEY QUESTIONS ANSWERED:

1. How big is the pipetting robots market?

2. Which region dominates the global pipetting robots market share?

3. What are the significant pipetting robots market trends?

4. What is the growth rate of the global pipetting robots market?

5. Who are the key players in the global pipetting robots market?

TABLE OF CONTENTS

1 SCOPE & COVERAGE

  • 1.1 MARKET DEFINITION
    • 1.1.1 INCLUSIONS
    • 1.1.2 EXCLUSIONS
    • 1.1.3 MARKET ESTIMATION CAVEATS
  • 1.2 SEGMENTS COVERED
    • 1.2.1 PRODUCT SEGMENTATION
    • 1.2.2 APPLICATION SEGMENTATION
    • 1.2.3 END-USER SEGMENTATION
    • 1.2.4 REGIONS & COUNTRIES COVERED
    • 1.2.5 BASE YEAR
  • 1.3 MARKET DERIVATION

2 PREMIUM INSIGHTS

  • 2.1 OPPORTUNITY POCKETS
    • 2.1.1 VENDOR SPECTRUM
    • 2.1.2 REGIONAL ANALYSIS
  • 2.2 OVERVIEW
  • 2.3 MARKET DYNAMICS
    • 2.3.1 MARKET SEGMENTATIONS

3 MARKET AT A GLANCE

4 INTRODUCTION

  • 4.1 OVERVIEW
    • 4.1.1 LAB AUTOMATION
    • 4.1.2 ADVANCING LAB AUTOMATION: PRECISION AND EFFICIENCY
    • 4.1.3 IMPACT OF COVID-19 ON THE PIPETTING ROBOTS MARKET

5 MARKET OPPORTUNITIES & TRENDS

  • 5.1 TECHNOLOGICAL ADVANCES ON PIPETTING ROBOTS
  • 5.2 INCREASING INTEGRATION & DEVELOPMENT OF NEW SOLUTIONS FOR PIPETTING ROBOTS
  • 5.3 RECENT INDUSTRIAL M&A

6 MARKET GROWTH ENABLERS

  • 6.1 INCREASING LAB AUTOMATION ACROSS SEVERAL INDUSTRIES
  • 6.2 RISING R&D AND LAB EXPANSION IN THE LIFE SCIENCES SECTOR
  • 6.3 SHIFT FROM PARTIAL TO FULLY AUTOMATED MODELS IN LABS

7 MARKET RESTRAINTS

  • 7.1 CONTINUING POPULARITY OF MANUAL & ELECTRONIC PIPETTES OVER PIPETTING ROBOTS
  • 7.2 ERGONOMICS WITH PIPETTING ROBOTS
  • 7.3 COST BURDEN ASSOCIATED WITH PIPETTING ROBOTS

8 MARKET LANDSCAPE

  • 8.1 MARKET OVERVIEW
    • 8.1.1 MARKET SEGMENTATION:
    • 8.1.2 MARKET BY PRODUCT
    • 8.1.3 MARKET BY APPLICATION
    • 8.1.4 MARKET BY END-USER
    • 8.1.5 MARKET BY GEOGRAPHY
  • 8.2 MARKET SIZE & FORECAST
  • 8.3 FIVE FORCES ANALYSIS
    • 8.3.1 THREAT OF NEW ENTRANTS
    • 8.3.2 BARGAINING POWER OF SUPPLIERS
    • 8.3.3 BARGAINING POWER OF BUYERS
    • 8.3.4 THREAT OF SUBSTITUTES
    • 8.3.5 COMPETITIVE RIVALRY

9 PRODUCT

  • 9.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 9.2 MARKET OVERVIEW
  • 9.3 FULLY AUTOMATED
    • 9.3.1 MARKET OVERVIEW
    • 9.3.2 MARKET SIZE & FORECAST
    • 9.3.3 MARKET BY GEOGRAPHY
  • 9.4 SEMI-AUTOMATED
    • 9.4.1 MARKET OVERVIEW
    • 9.4.2 MARKET SIZE & FORECAST
    • 9.4.3 MARKET BY GEOGRAPHY

10 APPLICATION

  • 10.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 10.2 MARKET OVERVIEW
  • 10.3 DRUG DISCOVERY & DEVELOPMENT
    • 10.3.1 MARKET OVERVIEW
    • 10.3.2 MARKET SIZE & FORECAST
    • 10.3.3 MARKET BY GEOGRAPHY
  • 10.4 CLINICAL DIAGNOSTICS
    • 10.4.1 MARKET OVERVIEW
    • 10.4.2 MARKET SIZE & FORECAST
    • 10.4.3 MARKET BY GEOGRAPHY
  • 10.5 OTHER APPLICATIONS
    • 10.5.1 MARKET OVERVIEW
    • 10.5.2 MARKET SIZE & FORECAST
    • 10.5.3 MARKET BY GEOGRAPHY

11 END-USER

  • 11.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 11.2 MARKET OVERVIEW
  • 11.3 PHARMA & BIOTECH COMPANIES
    • 11.3.1 MARKET OVERVIEW
    • 11.3.2 MARKET SIZE & FORECAST
    • 11.3.3 MARKET BY GEOGRAPHY
  • 11.4 ACADEMIC & RESEARCH CENTERS
    • 11.4.1 MARKET OVERVIEW
    • 11.4.2 MARKET SIZE & FORECAST
    • 11.4.3 MARKET BY GEOGRAPHY
  • 11.5 CLINICAL DIAGNOSTIC LABS
    • 11.5.1 MARKET OVERVIEW
    • 11.5.2 MARKET SIZE & FORECAST
    • 11.5.3 MARKET BY GEOGRAPHY
  • 11.6 OTHER END-USERS
    • 11.6.1 MARKET OVERVIEW
    • 11.6.2 MARKET SIZE & FORECAST
    • 11.6.3 MARKET BY GEOGRAPHY

12 GEOGRAPHY

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 GEOGRAPHIC OVERVIEW

13 NORTH AMERICA

  • 13.1 MARKET OVERVIEW
  • 13.2 MARKET SIZE & FORECAST
  • 13.3 PRODUCT
    • 13.3.1 MARKET SIZE & FORECAST
  • 13.4 APPLICATION
    • 13.4.1 MARKET SIZE & FORECAST
  • 13.5 END-USERS
    • 13.5.1 MARKET SIZE & FORECAST
  • 13.6 KEY COUNTRIES
    • 13.6.1 US: MARKET SIZE & FORECAST
    • 13.6.2 CANADA: MARKET SIZE & FORECAST

14 EUROPE

  • 14.1 MARKET OVERVIEW
  • 14.2 MARKET SIZE & FORECAST
  • 14.3 PRODUCT
    • 14.3.1 MARKET SIZE & FORECAST
  • 14.4 APPLICATION
    • 14.4.1 MARKET SIZE & FORECAST
  • 14.5 END-USER
    • 14.5.1 MARKET SIZE & FORECAST
  • 14.6 KEY COUNTRIES
    • 14.6.1 GERMANY: MARKET SIZE & FORECAST
    • 14.6.2 FRANCE: MARKET SIZE & FORECAST
    • 14.6.3 UK: MARKET SIZE & FORECAST
    • 14.6.4 RUSSIA: MARKET SIZE & FORECAST
    • 14.6.5 ITALY: MARKET SIZE & FORECAST
    • 14.6.6 SPAIN: MARKET SIZE & FORECAST
    • 14.6.7 POLAND: MARKET SIZE & FORECAST

15 APAC

  • 15.1 MARKET OVERVIEW
  • 15.2 MARKET SIZE & FORECAST
  • 15.3 PRODUCT
    • 15.3.1 MARKET SIZE & FORECAST
  • 15.4 APPLICATION
    • 15.4.1 MARKET SIZE & FORECAST
  • 15.5 END-USER
    • 15.5.1 MARKET SIZE & FORECAST
  • 15.6 KEY COUNTRIES
    • 15.6.1 CHINA: MARKET SIZE & FORECAST
    • 15.6.2 JAPAN: MARKET SIZE & FORECAST
    • 15.6.3 INDIA: MARKET SIZE & FORECAST
    • 15.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 15.6.5 AUSTRALIA: MARKET SIZE & FORECAST
    • 15.6.6 INDONESIA: MARKET SIZE & FORECAST

16 LATIN AMERICA

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
  • 16.3 PRODUCT
    • 16.3.1 MARKET SIZE & FORECAST
  • 16.4 APPLICATION
    • 16.4.1 MARKET SIZE & FORECAST
  • 16.5 END-USER
    • 16.5.1 MARKET SIZE & FORECAST
  • 16.6 KEY COUNTRIES
    • 16.6.1 BRAZIL: MARKET SIZE & FORECAST
    • 16.6.2 MEXICO: MARKET SIZE & FORECAST
    • 16.6.3 ARGENTINA: MARKET SIZE & FORECAST

17 MIDDLE EAST & AFRICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 PRODUCT
    • 17.3.1 MARKET SIZE & FORECAST
  • 17.4 APPLICATION
    • 17.4.1 MARKET SIZE & FORECAST
  • 17.5 END-USERS
    • 17.5.1 MARKET SIZE & FORECAST
  • 17.6 KEY COUNTRIES
    • 17.6.1 TURKEY: MARKET SIZE & FORECAST
    • 17.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 17.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
    • 17.6.4 UAE: MARKET SIZE & FORECAST

18 COMPETITIVE LANDSCAPE

  • 18.1 COMPETITION OVERVIEW
  • 18.2 MARKET SHARE ANALYSIS
    • 18.2.1 AGILENT TECHNOLOGIES
    • 18.2.2 BECKMAN COULTER
    • 18.2.3 BRAND GMBH + CO KG
    • 18.2.4 EPPENDORF
    • 18.2.5 HAMILTON COMPANY
    • 18.2.6 TECAN TRADING AG
    • 18.2.7 WATERS

19 KEY COMPANY PROFILES

  • 19.1 AGILENT TECHNOLOGIES
    • 19.1.1 BUSINESS OVERVIEW
    • 19.1.2 PRODUCT OFFERINGS
    • 19.1.3 KEY STRATEGIES
    • 19.1.4 KEY STRENGTHS
    • 19.1.5 KEY OPPORTUNITIES
  • 19.2 BECKMAN COULTER
    • 19.2.1 BUSINESS OVERVIEW
    • 19.2.2 PRODUCT OFFERINGS
    • 19.2.3 KEY STRATEGIES
    • 19.2.4 KEY STRENGTHS
    • 19.2.5 KEY OPPORTUNITIES
  • 19.3 BRAND GMBH + CO KG
    • 19.3.1 BUSINESS OVERVIEW
    • 19.3.2 PRODUCT OFFERINGS
    • 19.3.3 KEY STRATEGIES
    • 19.3.4 KEY STRENGTHS
    • 19.3.5 KEY OPPORTUNITIES
  • 19.4 EPPENDORF
    • 19.4.1 BUSINESS OVERVIEW
    • 19.4.2 PRODUCT OFFERINGS
    • 19.4.3 KEY STRATEGIES
    • 19.4.4 KEY STRENGTHS
    • 19.4.5 KEY OPPORTUNITIES
  • 19.5 HAMILTON COMPANY
    • 19.5.1 BUSINESS OVERVIEW
    • 19.5.2 PRODUCT OFFERINGS
    • 19.5.3 KEY STRATEGIES
    • 19.5.4 KEY STRENGTHS
    • 19.5.5 KEY OPPORTUNITIES
  • 19.6 TECAN TRADING AG
    • 19.6.1 BUSINESS OVERVIEW
    • 19.6.2 PRODUCT OFFERINGS
    • 19.6.3 KEY STRATEGIES
    • 19.6.4 KEY STRENGTHS
    • 19.6.5 KEY OPPORTUNITIES
  • 19.7 WATERS
    • 19.7.1 BUSINESS OVERVIEW
    • 19.7.2 PRODUCT OFFERINGS
    • 19.7.3 KEY STRATEGIES
    • 19.7.4 KEY STRENGTHS
    • 19.7.5 KEY OPPORTUNITIES

20 OTHER PROMINENT VENDORS

  • 20.1 ANALYTIK JENA GMBH+CO. KG
    • 20.1.1 BUSINESS OVERVIEW
    • 20.1.2 PRODUCT OFFERINGS
  • 20.2 CYBERTRON
    • 20.2.1 BUSINESS OVERVIEW
    • 20.2.2 PRODUCT OFFERINGS
  • 20.3 CORNING INCORPORATED
    • 20.3.1 BUSINESS OVERVIEW
    • 20.3.2 PRODUCT OFFERINGS
  • 20.4 ESSERT GMBH
    • 20.4.1 BUSINESS OVERVIEW
    • 20.4.2 PRODUCT OFFERINGS
  • 20.5 FLOW ROBOTICS
    • 20.5.1 BUSINESS OVERVIEW
    • 20.5.2 PRODUCT OFFERINGS
  • 20.6 FORMULATRIX
    • 20.6.1 BUSINESS OVERVIEW
    • 20.6.2 PRODUCT OFFERINGS
  • 20.7 GILSON INCORPORATED
    • 20.7.1 BUSINESS OVERVIEW
    • 20.7.2 PRODUCT OFFERINGS
  • 20.8 HUDSON ROBOTICS
    • 20.8.1 BUSINESS OVERVIEW
    • 20.8.2 PRODUCT OFFERINGS
  • 20.9 HIGHRES BIOSOLUTIONS
    • 20.9.1 BUSINESS OVERVIEW
    • 20.9.2 PRODUCT OFFERINGS
  • 20.10 INTEGRA BIOSCIENCES
    • 20.10.1 BUSINESS OVERVIEW
    • 20.10.2 PRODUCT OFFERINGS
  • 20.11 METTLER TOLEDO
    • 20.11.1 BUSINESS OVERVIEW
    • 20.11.2 PRODUCT OFFERINGS
  • 20.12 M2-AUTOMATION GMBH
    • 20.12.1 BUSINESS OVERVIEW
    • 20.12.2 PRODUCT OFFERINGS
  • 20.13 MGI TECH CO., LTD
    • 20.13.1 BUSINESS OVERVIEW
    • 20.13.2 PRODUCT OFFERINGS
  • 20.14 OPENTRONS
    • 20.14.1 BUSINESS OVERVIEW
    • 20.14.2 PRODUCT OFFERINGS
  • 20.15 REVVITTY (PERKINELMER INC.)
    • 20.15.1 BUSINESS OVERVIEW
    • 20.15.2 PRODUCT OFFERINGS
  • 20.16 SPT LABTECH
    • 20.16.1 BUSINESS OVERVIEW
    • 20.16.2 PRODUCT OFFERINGS
  • 20.17 SYNCHRON
    • 20.17.1 BUSINESS OVERVIEW
    • 20.17.2 PRODUCT OFFERINGS

21 REPORT SUMMARY

  • 21.1 KEY TAKEAWAYS
  • 21.2 STRATEGIC RECOMMENDATIONS

22 QUANTITATIVE SUMMARY

  • 22.1 MARKET BY GEOGRAPHY
  • 22.2 MARKET BY PRODUCT
  • 22.3 MARKET BY APPLICATION
  • 22.4 MARKET BY END-USER
  • 22.5 PRODUCT: MARKET BY GEOGRAPHY
    • 22.5.1 FULLY AUTOMATED: MARKET BY GEOGRAPHY
    • 22.5.2 SEMI-AUTOMATED: MARKET BY GEOGRAPHY
  • 22.6 APPLICATION: MARKET BY GEOGRAPHY
    • 22.6.1 DRUG DISCOVERY & DEVELOPMENT: MARKET BY GEOGRAPHY
    • 22.6.2 CLINICAL DIAGNOSTICS: MARKET BY GEOGRAPHY
    • 22.6.3 OTHER APPLICATIONS: MARKET BY GEOGRAPHY
  • 22.7 END-USER: MARKET BY GEOGRAPHY
    • 22.7.1 PHARMA & BIOTECH COMPANIES: MARKET BY GEOGRAPHY
    • 22.7.2 ACADEMIC & RESEARCH CENTERS: MARKET BY GEOGRAPHY
    • 22.7.3 CLINICAL DIAGNOSTIC LABS: MARKET BY GEOGRAPHY
    • 22.7.4 OTHER END-USERS: MARKET BY GEOGRAPHY

23 APPENDIX

  • 23.1 RESEARCH METHODOLOGY
  • 23.2 RESEARCH PROCESS
  • 23.3 REPORT ASSUMPTIONS & CAVEATS
    • 23.3.1 KEY CAVEATS
    • 23.3.2 CURRENCY CONVERSION
  • 23.4 ABBREVIATIONS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦